Login
$CHRN
$14.63 -$0.14 (0.95%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Aug 31, 2026
Q4 FY2026
As of May 31, 2026
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q3 FY2025
As of Mar 31, 2025
Q2 FY2025
As of Dec 31, 2024
Q1 FY2025
As of Sep 30, 2024
Q4 FY2024
As of Jun 30, 2024
Q3 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Dec 31, 2023
Q1 FY2024
As of Sep 30, 2023
Q4 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Mar 31, 2023
Q2 FY2023
As of Dec 31, 2022
Q1 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Mar 31, 2022
Q2 FY2022
As of Dec 31, 2021
ASSETS
Current assets:
Cash and restricted cash
Cash
Restricted cash
Total cash and restricted cash
Accounts receivable
Inventories
Prepaid expenses and other current assets
Current assets held for sale
Total current assets
Property and equipment, net
Operating lease right of use assets, net
Intangible assets, net
Finance lease right of use assets, net
Goodwill
Other assets
TOTAL ASSETS
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued liabilities
Current portion of operating lease liability
Current portion of finance lease liability
Current portion of debt
Current deferred revenue
Convertible promissory note, net
Current liabilities held for sale
Total current liabilities
Long-term portion of operating lease liability
Other non-current liabilities
Long-term portion of finance lease liability
Long-term debt
Long-term portion of deferred revenue
Warrant liabilities
Total liabilities
Temporary equity:
Convertible preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 issued and outstanding as of August 31, 2026; 2,926 issued and outstanding as of May 31, 2026, with a $2,926 redemption value
Stockholders' equity:
Convertible preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and 2024
Common stock, $0.001 par value; 290,000,000 shares authorized; 145,637,452 and 145,212,325 shares issued and outstanding as of August 31, 2026 and May 31, 2026, respectively
Additional paid in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support